Global Contrast Media Injectors Market is valued approximately at USD 1.2 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 7.4% over the forecast period 2020-2027. Contrast media injectors (CMI) has been developed and employed for injecting contrast agents into the human’s body, to enhance the range of tissues for conducting medical imaging procedures. Presently, several advancements have been performed with contrast media injector technology, such as reduce costs by cutting down contrast waste and automated data assortment for the dose a patient takes. The automated injector system not only accurately manages the amount of contrast waste; but also offers personalized doses for patients by utilizing information collected from a picture archiving and communication system (PACS) or electronic medical record (EMR). Contrast dose recording software further provides new potential for radiology departments that streamline the usage of contrast media, which may drive the market growth during the forecast period. Furthermore, rising prevalence of chronic diseases such as cancer and cardiovascular disease, increasing regulatory approvals of contrast agents, and rising investment and government funding in the development of contrast media injectors are the few factors responsible for the CAGR of the market during the forecast period. According to the International Agency for Research on Cancer (IARC), around 18.1 million new cancer cases and 9.6 million cancer deaths were reported throughout the world in 2018. Also, the global prevalence of cancer is projected to grow to around 27.5 million new cancer cases and nearly 16.3 million cancer deaths by the year 2040. This, in turn, is likely to strengthen the demand for contrast media injector, globally. However, the high development cost of contrast media injectors & accessories and unfavorable outcomes of contrast agents are the few factors inhibiting the market growth over the forecast period of 2020-2027.

The regional analysis of the global Contrast Media Injectors market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the increasing demand for minimally invasive procedures, along with the wide presence of market players in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in prevalence of cancer and cardiovascular diseases, coupled with improving healthcare infrastructure in the developing nations, such as China and India, are the few factors creating a lucrative opportunity for the growth of the cancer vaccine market in the Asia-Pacific region.

Major market player included in this report are:
Bracco Group
Bayer HealthCare LLC
Guerbet Group
Medtron AG
GE Healthcare
ulrich GmbH & Company KG
Nemoto Kyorindo Co., Ltd.
Sino Medical-Device Technology Co., Ltd.
APOLLO RT Co. Ltd.
VIVID Imaging

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Single Head Injectors
Dual Head Injectors
Syringeless Injectors

By Product:
Injector Systems
Consumables

By Application:
Radiology
Interventional Cardiology
Interventional Radiology

By End-Use:
Hospitals
Diagnostic Centers
Ambulatory Surgery Centers (ASCs)

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Contrast Media Injectors Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors